To confirm above results, we knocked down TCF4 and LEF1 in HCC cells with DDX39 overexpression to inactivate β-catenin pathway (Fig. 6a), TCF4 and LEF1 are the co-activators of Wnt/β-catenin pathway. Here, LEF1 is linked to hepatocellular carcinoma.